By proceeding, you agree to our Terms of Use and Privacy Policy.
David Fairlamb is currently Director of Regulatory Affairs at SolasCure Ltd, where he leads efforts to gain regulatory approval for Aurase Wound Gel; a new enzymatic debridement agent.
Talks About #clinicaltrials #pharmaceuticalindustry
Preferred Locations #Europe
The Advanced Wound Care Summit EU is the first industry-led, EU-focused, forum on commercialising innovative wound care products.